Search for: "Hi-Tech Pharmaceuticals Incorporated"
Results 1 - 20
of 29
Sort by Relevance
|
Sort by Date
4 Feb 2024, 4:40 pm
The conference will be returning with a new format to incorporate the new and exciting developments in Information, Technology and Media Law. [read post]
2 Jan 2024, 12:56 pm
Thus, by my tally there were 25 securities class action lawsuits filed against companies in the 283 SIC Code Industry Group (Drugs), including 17 in the 2834 SIC Code category (Pharmaceutical Preparations). [read post]
17 Jul 2023, 6:13 am
This was the real reason, he said, that his Republican Colleagues were taking aim at the agency. [read post]
17 Jul 2023, 2:02 am
And for a major pharmaceutical company, we brought organizational storytelling to a technology training session. [read post]
16 May 2022, 12:16 pm
Qualcomm Incorporated (licensee appellate standing) and Amgen Inc. v. [read post]
11 Nov 2021, 2:07 pm
I would like to thank Nessim for allowing me to publish his article as a guest post on this site. [read post]
31 Aug 2021, 6:36 am
His experience overseeing an independent country’s unique data regime also deemed ‘adequate’ to the EU’s General Data Protection Regulation (GDPR) will be vital. [read post]
4 Jan 2021, 1:26 pm
The suits filed against life sciences and high-tech companies taken together represented about 28.5% of all 2020 federal court securities class action lawsuits. [read post]
17 Mar 2020, 1:32 pm
Atovaquone Oral Suspension, USP 750 mg/5mL, has been recalled by KVK Tech, Inc. due to defects resulting from exposure to extreme temperatures during shipping. [read post]
7 Mar 2017, 3:16 am
The following guest post by Professor Paul Janicke ties-in with his new article published at: Paul M. [read post]
18 Apr 2016, 9:58 am
by Dennis Crouch Cuozzo: Prof Mann provides his preview of the April 25 oral arguments in Cuozzo v. [read post]
17 Mar 2016, 2:45 am
Post Grant Admin: Click-to-Call Tech, LP v. [read post]
4 Mar 2016, 12:25 pm
Post Grant Admin: Click-to-Call Tech, LP v. [read post]
17 Oct 2015, 5:29 am
In Joiner, the high Court rejected WOE, over the dissent of a single justice,[5] but some of the inferior federal courts have embraced the dissent to the exclusion of the majority’s clear holding, as well as the incorporation of that holding into the revised Rule 702.[6] An interesting case of judicial disregard. [read post]
15 Jun 2014, 6:18 pm
Procedural HistoryZydus Pharmaceuticals USA, Inc. [read post]
3 Jun 2013, 12:09 pm
Scott Hemphill, Paying for Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem, 81 N.Y.U. [read post]
21 Feb 2013, 9:25 am
Explaining Creativity is his big book on this. [read post]
11 Feb 2012, 9:51 am
We should consider incorporating it into at least a few aspects of IP. [read post]
26 Feb 2011, 3:47 pm
Cir. 2006) (affirming the district court's finding of infringement by equivalence and stating that separate patentability of the accused pharmaceutical formulation did not outweigh substantial evidence of its equivalence); Fiskars, Inc. v. [read post]
29 Nov 2010, 12:23 am
(Docket Report) Trading Tech’s – Answer and counterclaims struck sua sponte: Trading Techs. [read post]
